Literature DB >> 4985792

Distribution and elimination of exogenous alpha1-antitrypsin.

S Makino, C E Reed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4985792

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  10 in total

1.  An increase in plasma concentrations of granulocyte elastase during and after bench surgery of the liver.

Authors:  K Irita; T Taniyama; H Okamoto; H Inoue; M Umeki; S Inaba; S Taniguchi; Y Sakaguchi; K Mazuda; M Yamakawa; J Yoshitake; S Takahashi
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

Review 2.  Antitrypsin and the liver.

Authors:  P W Brunt
Journal:  Gut       Date:  1974-07       Impact factor: 23.059

3.  Pathogenesis of deficient serum alpha1-antitrypsin in the type ZZ homozygote.

Authors:  P T Rowley; M L Sevilla; R H Schwartz
Journal:  Biochem Genet       Date:  1974-09       Impact factor: 1.890

4.  The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA.

Authors:  D H Perlmutter; R M Kay; F S Cole; T H Rossing; D Van Thiel; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  The role of elastases in the development of emphysema.

Authors:  Charles Kuhn; Robert M Senior
Journal:  Lung       Date:  1978-12       Impact factor: 2.584

Review 6.  Measurement of soluble proteins in lung secretions.

Authors:  R A Stockley
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

7.  A model of decreased functional alpha-1-proteinase inhibitor. Pulmonary pathology of dogs exposed to chloramine T.

Authors:  W R Abrams; A B Cohen; V V Damiano; A Eliraz; P Kimbel; D R Meranze; G Weinbaum
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

8.  Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.

Authors:  Eeva Piitulainen; Elisabeth Bernspång; Sven Björkman; Erik Berntorp
Journal:  Eur J Clin Pharmacol       Date:  2003-05-01       Impact factor: 2.953

9.  Inheritance and genetic linkage of transcobalamin II.

Authors:  S Y Yang; P Coleman; H D Ochs; B Dupont
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

10.  Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.

Authors:  J E Gadek; H G Klein; P V Holland; R G Crystal
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.